FACT Board members met during the TCT Meetings with its newest accreditation partner, Sociedade Brasileira de Transplante de Medula Óssea (SBTMO) to continue planning to assist Brazilian transplant centers to achieve FACT-SBTMO Accreditation.
Andrea Kondo, who is a member of SBTMO and is part of the Accreditation Committee, was responsible for presenting to the Latin American Bone Marrow Transplant Group (LABMT) during the TCT Meetings the steps already taken in the FACT-SBTMO Accreditation Program. Dr. Kondo announded there are already 24 hematopoietic stem cell transplant centers that want to participate in the program and achieve certification. This is because “the accreditation attests to the institution that it offers safety, excellence and quality in each of the processes practiced by it, not only in the part of the clinical program, but also in the collection of progenitor cell products, in the processing and infusion of cells -trunk, ”explains Andrea.
“These centers that have already joined and the others that have been contacting us, show us that there is really a movement to strengthen and improve our HSCT practice, which is a gain not only for services, but especially for patients” declared the president of SBTMO, Nelson Hamerschlak.
It is worth mentioning that Brazil was the pioneer in Latin America, since 2012, to gain FACT recognition, through the accreditation of Hospital Israelita Albert Einstein (HIAE), which has been re-accredited in 2015 and 2018.
Educational efforts to support the Brazilian centers in preparing for accreditation are underway. Andrea Kondo is currently working on the development of educational tools and webinars to assist transplant centers. Planning is underway for a FACT Inspection & Accreditation workshop scheduled to take place during the SBTMO Annual Congress slated for October 2020 in Sao Paolo.